results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
Published 1 year ago • 300 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
4:55
results of the phase ib/ii trial of obinutuzumab-atezolizumab-lenalidomide for r/r fl
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
2:28
results from the cartitude-2 trial
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
4:54
beakertv | meet brenda montgomery, msl at biomea fusion
-
4:33
what are the current treatment options for double-hit lymphoma?
-
2:15
updates from the phase ii aern trial: nivolumab and radiotherapy for the treatment of r/r hl
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
1:44
insights into the phase ii tidal study
-
1:51
what do the elm-2 results tell us about the efficacy of odronextamab for r/r dlbcl?
-
1:15
results of phase ii study of tislelizumab in r/r nk/t-cell neoplasms
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
2:37
potential second-line treatment for indolent lymphoma
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml